Fidelity Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,044,450
| Closed | -$685M | – | 4482 |
|
|
2020
Q3 | $685M | Sell |
13,044,450
-4,611,795
| -26% | -$191M | 0.07% | 254 |
|
|
2020
Q2 | $587M | Buy |
17,656,245
+64,904
| +0.4% | +$2.07M | 0.06% | 271 |
|
|
2020
Q1 | $478M | Buy |
17,591,341
+233,838
| +1% | +$6.51M | 0.07% | 265 |
|
|
2019
Q4 | $342M | Buy |
17,357,503
+2,551,408
| +17% | +$40.8M | 0.04% | 431 |
|
|
2019
Q3 | $192M | Buy |
14,806,095
+14,404
| +0.1% | +$174K | 0.02% | 639 |
|
|
2019
Q2 | $184M | Buy |
14,791,691
+15,327
| +0.1% | +$204K | 0.02% | 669 |
|
|
2019
Q1 | $215M | Buy |
14,776,364
+5,636
| +0% | +$72K | 0.03% | 617 |
|
|
2018
Q4 | $163M | Buy |
14,770,728
+3,023,513
| +26% | +$42.1M | 0.02% | 660 |
|
|
2018
Q3 | $309M | Buy |
11,747,215
+113,380
| +1% | +$3.07M | 0.03% | 498 |
|
|
2018
Q2 | $238M | Buy |
11,633,835
+109,583
| +1% | +$2.35M | 0.03% | 603 |
|
|
2018
Q1 | $209M | Buy |
11,524,252
+70,693
| +0.6% | +$1.18M | 0.02% | 665 |
|
|
2017
Q4 | $160M | Buy |
11,453,559
+23,375
| +0.2% | +$316K | 0.02% | 779 |
|
|
2017
Q3 | $211M | Buy |
11,430,184
+304,991
| +3% | +$5.1M | 0.03% | 661 |
|
|
2017
Q2 | $188M | Buy |
11,125,193
+351,743
| +3% | +$5.35M | 0.02% | 700 |
|
|
2017
Q1 | $144M | Buy |
10,773,450
+93,702
| +0.9% | +$1.47M | 0.02% | 837 |
|
|
2016
Q4 | $161M | Buy |
10,679,748
+68,356
| +0.6% | +$903K | 0.02% | 776 |
|
|
2016
Q3 | $124M | Sell |
10,611,392
-21,487
| -0.2% | -$253K | 0.02% | 881 |
|
|
2016
Q2 | $115M | Buy |
10,632,879
+265,713
| +3% | +$2.74M | 0.02% | 914 |
|
|
2016
Q1 | $95.8M | Buy |
10,367,166
+22,077
| +0.2% | +$238K | 0.01% | 981 |
|
|
2015
Q4 | $154M | Buy |
10,345,089
+27,429
| +0.3% | +$459K | 0.02% | 768 |
|
|
2015
Q3 | $169M | Buy |
10,317,660
+611,241
| +6% | +$12.5M | 0.02% | 714 |
|
|
2015
Q2 | $221M | Buy |
9,706,419
+3,164,605
| +48% | +$63M | 0.03% | 643 |
|
|
2015
Q1 | $99.4M | Buy |
6,541,814
+3,725,000
| +132% | +$48.4M | 0.01% | 1030 |
|
|
2014
Q4 | $33.9M | Sell |
2,816,814
-99,311
| -3% | -$1.14M | ﹤0.01% | 1509 |
|
|
2014
Q3 | $33.1M | Buy |
2,916,125
+15,811
| +0.5% | +$180K | ﹤0.01% | 1511 |
|
|
2014
Q2 | $35M | Sell |
2,900,314
-191,434
| -6% | -$2.26M | ﹤0.01% | 1515 |
|
|
2014
Q1 | $36M | Buy |
3,091,748
+165,934
| +6% | +$2.81M | 0.01% | 1477 |
|
|
2013
Q4 | $51.7M | Sell |
2,925,814
-17,220
| -0.6% | -$289K | 0.01% | 1302 |
|
|
2013
Q3 | $42.4M | Sell |
2,943,034
-354,746
| -11% | -$5.43M | 0.01% | 1369 |
|
|
2013
Q2 | $49.7M | Buy |
+3,297,780
| New | +$43.5M | 0.01% | 1247 |
|
Fidelity Investments's MNTA Position: Q4 2020 in Review
Fidelity Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 13,044,450 shares — an estimated $685M sold.
Fidelity Investments first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $685M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Fidelity Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Fidelity Investments sold 13,044,450 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $685M.
- Fidelity Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Fidelity Investments's Momenta Pharmaceuticals, Inc. position peaked at $685M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Fidelity Investments's 13F filing for Q4 2020, filed 8 Feb 2021.